Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Highlighting top abstracts for the annual radiation oncology conference
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Driving advances in cancer care
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Unique molecular features found in young-onset disease
Emerging research and innovation shared
Retrospective study aims to better stratify risk of disease recurrence
Timely referral to hospice care reduces emergency room admissions
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Distinct molecular features found in five subtypes of disease